Propofol Versus Dexmedetomidine Effect on Prevention Emergence Agitation

Launched by AIN SHAMS UNIVERSITY · Mar 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how two different medications, Propofol and Dexmedetomidine, help prevent a condition called Emergence Agitation (EA) in children who are having squint surgery. Emergence Agitation can cause children to feel restless, confused, and upset after waking up from anesthesia, which is a type of medicine used to make them sleep during the surgery. The trial aims to find out which of these two drugs is better at minimizing these troubling symptoms in children ages 3 to 7.

To be eligible for the trial, children must be between 3 and 7 years old and generally healthy, meaning they are classified as ASA Physical Status Class I or II. They will be monitored closely during and after the surgery to see how well the medications work. It’s important to note that children with certain health issues or allergies to the study drugs will not be able to participate. If you have a child who qualifies and you choose to enroll them, they will be part of a study that could help improve care for kids undergoing similar surgeries in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Pediatric patients from 3 to 7 years.
• • American Society of Anesthesiologists (ASA) Physical Status Class-I and II.
• • Patients undergo squint surgery.
• Exclusion Criteria:
• • Declining to give written informed consent by patient legal guardian.
• • Age younger than 3 years or older than 7 years.
• • ASA classification ≥ III.
• • History of allergy to the medications used in the study or egg products.
• • Psychiatric disorder
• • Other co-morbidities or congenital anomalies or neurological.